NEW YORK ( TheStreet) -- CHANGE IN RATINGSAES ( AES) downgraded at UBS from Buy to Neutral, UBS said. $14 price target. Valuation call, as the stock is up 24% year-to-date. Boston Scientific ( BSX) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Stock is attractively valued as the pipeline should drive positive sales growth in 2014. Cablevision ( CVC) downgraded at Citi from Buy to Neutral, Citigroup said. $17 price target. Cash flow contraction is eroding value. Forest Laboratories ( FRX) rated new Underperform at BMO. $27 price target. Expect another earnings trough in 2015 to 2017. Granite Construction ( GVA) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $28 price target. No longer see downside to earnings expectations. Limited Brands ( LTD) downgraded at BMO from Buy to Neutral, BMO Capital said. Buy-side earnings expectations may prove to be optimistic. Micron ( MU) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Valuation call, as the stock is already factoring in higher memory pricing.
Rent-A-Center ( RCII) downgraded at Canaccord from Buy to Hold, Canaccord Genuity said. Core RTO business remains weak. $37 price target. American Realty Capital Properties ( ARCP) was upgraded to hold at TheStreet Ratings. Tesla Motors ( TSLA) was upgraded to buy at TheStreet Ratings.